Evaluation of comparative clinical efficacy of Yavagodhumadi Upanaha Swedana, Koladi Upanaha Swedana and 1% topical Diclofenac sodium gel in the management of Janu Sandhigatavata (Osteoarthritis of knee)

Abhishek Bhattacharjee0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•1.Patient who are willing to participate in the study and ready to give a written informed consent.
•2.Subjects of either sex in the age group of 40 to 60 years.
•3.Patients with a diagnosis of knee Osteoarthritis as per American College of Rheumatology clinical and radiographic criteria.
•4.Knee Osteoarthritis confirmed by radiological changes as per Kellgren & Lawrence radiological scale of at least grade 2 in X-ray.
•5.Osteoarthritis Patients with mean baseline pain intensity of 4 in Visual Analogue Scale (VAS) of 10 in one or both knees.

•1.The subjects who are known to have congenital dysplasia, gouty arthritis, rheumatoid arthritis, psoriatic arthritis and other autoimmune diseases, malignancies, history of any trauma or fractured joint or surgical history to the joint.
•2.Patients with gross disability in performing daily normal routine i.e., bedridden subjects or confined to a wheelchair, having any deformity of knee, hip or back altering the gait and posture.
•3.Patient who has been administered any chondroprotective drugs, intra-articular injection into the affected knee joint or invasive measures have been performed at the affected joint or systemic medication with corticosteroids during the preceding 3 months.
•4.Patients on medication likely to influence evaluation.
•5.Pregnant or lactating women
•6.Patients with an acute mental disorder, a serious acute organic disease, or any serious comorbidity that made it impossible to participate in the trial interventions.

发起方

Abhishek Bhattacharjee